Editorials
Covid-19 controversies: the tocilizumab chapter
BMJ 2021; 372 doi: https://doi.org/10.1136/bmj.n244 (Published 27 January 2021) Cite this as: BMJ 2021;372:n244Linked Research
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019